Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ARAY

ARAY - Accuray Inc Stock Price, Fair Value and News

2.61USD-0.09 (-3.33%)Market Closed
Watchlist

Market Summary

USD2.61-0.09
Market Closed
-3.33%

ARAY Stock Price

View Fullscreen

ARAY RSI Chart

ARAY Valuation

Market Cap

258.8M

Price/Earnings (Trailing)

-17.79

Price/Sales (Trailing)

0.58

EV/EBITDA

59.7

Price/Free Cashflow

33.87

ARAY Price/Sales (Trailing)

ARAY Profitability

Operating Margin

33.92%

EBT Margin

-2.38%

Return on Equity

-30.53%

Return on Assets

-3.05%

Free Cashflow Yield

2.95%

ARAY Fundamentals

ARAY Revenue

Revenue (TTM)

447.5M

Rev. Growth (Yr)

-6.55%

Rev. Growth (Qtr)

3.22%

ARAY Earnings

Earnings (TTM)

-14.5M

Earnings Growth (Yr)

-413.39%

Earnings Growth (Qtr)

-224.05%

Breaking Down ARAY Revenue

Last 7 days

5.3%

Last 30 days

-1.8%

Last 90 days

8.2%

Trailing 12 Months

-10.0%

How does ARAY drawdown profile look like?

ARAY Financial Health

Current Ratio

1.58

Debt/Equity

3.56

Debt/Cashflow

0.12

ARAY Investor Care

Shares Dilution (1Y)

3.85%

Diluted EPS (TTM)

-0.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023439.3M447.6M455.0M447.5M
2022430.8M429.9M419.0M417.4M
2021380.3M396.3M418.4M437.2M
2020405.4M382.9M378.7M377.3M
2019415.3M418.8M413.9M409.0M
2018403.2M404.9M408.4M411.8M
2017366.3M383.4M387.9M400.7M
2016405.6M398.8M395.7M374.3M
2015380.1M379.8M387.1M397.8M
2014352.3M369.4M375.2M379.7M
2013331.6M316.0M309.9M325.7M
2012383.9M409.2M391.5M362.9M
2011222.1M222.3M284.7M336.8M
20100221.6M221.8M222.0M

Tracking the Latest Insider Buys and Sells of Accuray Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 03, 2024
corradetti gina
sold
-38,729
2.7411
-14,129
vp, cao and controller
Jan 03, 2024
pervaiz ali
sold
-5,800
2.7411
-2,116
svp chief financial officer
Dec 01, 2023
spine patrick
sold
-36,652
2.4712
-14,832
svp, chief admin officer
Dec 01, 2023
pervaiz ali
sold
-33,271
2.4713
-13,463
svp chief financial officer
Dec 01, 2023
chew jesse
sold
-73,564
2.4711
-29,770
svp, general counsel
Dec 01, 2023
winter suzanne c
sold
-161,624
2.4717
-65,390
president
Dec 01, 2023
hoge michael
sold
-47,482
2.4715
-19,212
senior vp global operations
Dec 01, 2023
chalke sandeep
sold
-36,041
2.4711
-14,585
svp, chief commercial officer
Nov 30, 2023
scott byron c
acquired
-
-
56,603
-
Nov 30, 2023
chew jesse
acquired
-
-
132,075
svp, general counsel

1–10 of 50

Which funds bought or sold ARAY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
2.31
12,000
189,000
-%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
1,404
36,108
-%
Feb 15, 2024
JANE STREET GROUP, LLC
added
210
87,230
126,422
-%
Feb 15, 2024
BARCLAYS PLC
added
254
337,000
463,000
-%
Feb 15, 2024
State of Wyoming
reduced
-19.73
-23,447
118,823
0.02%
Feb 15, 2024
Legal & General Group Plc
unchanged
-
1,106
28,450
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
37.00
37.00
-%
Feb 14, 2024
Bayesian Capital Management, LP
sold off
-100
-38,080
-
-%
Feb 14, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC
reduced
-86.81
-593,047
94,324
-%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
added
119
150,782
268,579
-%

1–10 of 41

Are Funds Buying or Selling ARAY?

Are funds buying ARAY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ARAY
No. of Funds

Unveiling Accuray Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
archon capital management llc
6.71%
6,512,479
SC 13G/A
Feb 13, 2024
vanguard group inc
5.43%
5,269,207
SC 13G
Feb 12, 2024
neuberger berman group llc
5.66%
5,495,414
SC 13G/A
Jan 25, 2024
blackrock inc.
8.5%
8,295,754
SC 13G
Feb 13, 2023
archon capital management llc
6.51%
6,104,738
SC 13G
Feb 10, 2023
neuberger berman group llc
5.58%
5,229,865
SC 13G/A
Jul 08, 2022
blackrock inc.
3.8%
3,533,198
SC 13G
Feb 11, 2022
neuberger berman group llc
5.57%
5,061,664
SC 13G/A
Feb 07, 2022
blackrock inc.
8.4%
7,635,957
SC 13G/A
Feb 11, 2021
neuberger berman group llc
5.96%
5,532,870
SC 13G/A

Recent SEC filings of Accuray Inc

View All Filings
Date Filed Form Type Document
Feb 13, 2024
SC 13G
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 07, 2024
10-Q
Quarterly Report
Jan 31, 2024
8-K
Current Report
Jan 25, 2024
SC 13G
Major Ownership Report
Jan 05, 2024
4
Insider Trading
Jan 05, 2024
4
Insider Trading
Dec 04, 2023
4
Insider Trading
Dec 04, 2023
4
Insider Trading

What is the Fair Value of ARAY?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Accuray Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
207.1B
40.1B
0.08% 5.41%
36.19
5.16
-8.12% -17.45%
70.3B
19.5B
1.90% -2.48%
56
3.61
4.02% -22.04%
24.2B
3.8B
13.67% -2.23%
66.83
6.37
-1.48% -28.97%
21.3B
14.9B
3.05% 1.38%
8.03
1.43
2.01% 209.17%
MID-CAP
10.0B
12.7B
2.56% -12.12%
22.51
0.79
0.68% -30.25%
9.9B
2.7B
6.89% -27.73%
-15.59
3.72
-4.68% 82.43%
9.3B
3.5B
8.76% 25.90%
32.84
2.68
4.97% 18.89%
7.1B
3.9B
-8.15% -6.44%
-32.48
1.81
-2.62% 73.16%
3.5B
342.6M
-1.40% 20.18%
-287.71
10.08
42.19% 84.12%
2.6B
6.6B
-4.32% -4.67%
13.13
0.4
2.61% 0.52%
SMALL-CAP
1.0B
3.1B
8.08% -63.68%
-2.41
0.33
7.95% -543.98%
363.5M
163.3M
8.18% -20.52%
-14.79
2.23
7.14% -56.09%
238.7M
329.5M
3.17% -52.24%
-16.91
0.72
0.49% 64.22%
74.1M
50.3M
4.50% -30.54%
-4.89
1.47
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.37
1.19
5.77% 8.23%

Accuray Inc News

Latest updates
Yahoo Finance17 hours ago
Yahoo Finance20 Feb 202404:27 pm
InvestorsObserver13 Feb 202402:58 pm
InvestorsObserver01 Feb 202408:00 am
Simply Wall St2 months ago
Zacks Investment Research3 months ago

Accuray Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.2%10710411811811596.0011096.0011610711110397.0085.0095.0010099.0090.00117103107
Cost Of Revenue10.8%71.0064.0081.0079.0072.0062.0067.0061.0074.0068.0067.0063.0057.0050.0055.0060.0061.0057.0071.0063.0064.00
Gross Profit-9.1%36.0039.0038.0039.0043.0035.0043.0035.0043.0040.0044.0040.0041.0035.0040.0039.0038.0033.0046.0040.0038.00
Operating Expenses6.9%40.0037.0038.0036.0040.0037.0041.0035.0039.0037.0040.0035.0033.0030.0035.0031.0034.0037.0043.0038.0039.00
  S&GA Expenses10.9%11.0010.0011.0011.0014.0011.0014.0011.0013.0011.0013.0011.0010.009.0012.0011.0011.0013.0015.0013.0015.00
  R&D Expenses9.0%15.0014.0014.0014.0015.0014.0015.0014.0015.0014.0015.0013.0012.0012.0012.0011.0013.0013.0016.0013.0014.00
EBITDA Margin-54.2%0.01*0.03*0.02*0.02*0.01*0.02*0.03*0.03*0.03*0.04*0.05*0.08*---------
Interest Expenses0%3.003.003.003.003.002.002.002.002.002.00-----------
Income Taxes-54.6%1.002.001.001.001.000.002.000.000.000.000.001.000.000.000.000.001.001.001.000.000.00
Earnings Before Taxes-743.1%-8.74-1.04-1.981.00-0.82-5.11-1.42-0.641.00-0.60-10.690.005.001.000.003.0011.00-8.72-0.54-0.95-4.19
EBT Margin-298.0%-0.02*-0.01*-0.02*-0.01*-0.02*-0.02*0.00*-0.03*-0.02*-0.01*-0.01*0.02*---------
Net Income-224.0%-9.62-2.97-2.561.00-1.87-5.45-3.45-1.050.00-1.03-11.09-0.395.000.00-0.153.0011.00-9.36-1.40-1.18-4.64
Net Income Margin-117.5%-0.03*-0.01*-0.02*-0.02*-0.03*-0.02*-0.01*-0.03*-0.03*-0.02*-0.02*0.01*---------
Free Cashflow34.5%-6.34-9.681.0023.00-19.51-1.23-6.04-22.8332.00-10.065.0016.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-0.1%476477479476469466473469476476480487478465491490479464438406386
  Current Assets-0.9%331334338343337335351347351351353359345332357352339341344310289
    Cash Equivalents-3.2%74.0077.0089.0089.0068.0082.0090.0099.0012510611813111797.0011093.0010088.0088.0065.0065.00
  Inventory3.5%155150145151156153142138124126126137139141134136131129121124119
  Net PPE3.8%26.0025.0021.0012.0011.0011.0013.0012.0012.0012.0012.0012.0014.0015.0015.0016.0017.0017.0017.0020.0021.00
  Goodwill0.2%58.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.0058.00
Liabilities0.7%429426426421417419420418425430411408400397427430423423388358340
  Current Liabilities3.9%209201199192185193209201204188192193179169182180178176192181169
  Short Term Borrowings8.2%7.006.006.006.006.006.009.008.008.004.004.0019.0013.006.00-------
  Long Term Debt-100.0%-170172173174171172173174194170164168174189191184188160146137
    LT Debt, Non Current-1.0%168170172173174171172173174194170164168174189191184188160146137
Shareholder's Equity-6.5%48.0051.0054.0055.0052.0047.0053.0052.0051.0046.0069.0079.0078.0067.0064.0060.0056.0041.0050.0048.0046.00
  Retained Earnings-1.9%-514-505-502-499-500-497-492-489-488-488-488-476-476-481-481-481-484-494-485-484-482
  Additional Paid-In Capital0.6%561558555552550546543539537532555555551548546542540537535531528
Shares Outstanding2.5%99.0097.0097.0096.0095.0094.0093.0092.0092.0091.0092.0092.00---------
Float-----163,067---365---309---176---227
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations40.7%-5,093-8,5918,88124,626-18,01446.00-4,644-21,76732,611-8,6006,19515,90319,284-2,87018,819-12,12116,454-24,6219,086-7,129-13,775
  Share Based Compensation-3.3%2,3142,3922,4521,5593,1262,9162,6892,7002,6952,5162,2352,4892,3642,2442,2872,0162,1491,7002,8222,8801,687
Cashflow From Investing-14.4%-1,249-1,092-7,976-1,899-1,534-1,272-1,396-1,062-803-1,456-893-260-677-569-794-401-1,266-1,267-1,075-1,018-616
Cashflow From Financing82.9%-257-1,500-522-1,5004,275-4,365141-1,000-13,510-1,000-19,4121,630136-11,159-1,6305,442-4,56627,45013,7608,8128,327

ARAY Income Statement

2023-12-31
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net revenue:    
Total net revenue$ 107,238$ 114,760$ 211,130$ 211,253
Cost of revenue:    
Total cost of revenue[1]71,33671,793135,735133,689
Gross profit35,90242,96775,39577,564
Operating expenses:    
Research and development[2]15,28114,64129,29428,733
Selling and marketing11,36113,58621,60524,381
General and administrative13,22412,03526,24723,927
Total operating expenses39,86640,26277,14677,041
Income (loss) from operations(3,964)2,705(1,751)523
Income (loss) from equity method investment, net(427)(699)4(1,067)
Other expense, net(4,352)(2,831)(8,033)(5,389)
Loss before provision for income taxes(8,743)(825)(9,780)(5,933)
Provision for income taxes8781,0492,8101,390
Net loss$ (9,621)$ (1,874)$ (12,590)$ (7,323)
Net loss per share - basic$ (0.1)$ (0.02)$ (0.13)$ (0.08)
Net loss per share - diluted$ (0.1)$ (0.02)$ (0.13)$ (0.08)
Weighted average common shares used in computing net loss per share:    
Basic97,77694,56797,16594,048
Diluted97,77694,56797,16594,048
Other comprehensive income (loss):    
Net Income (Loss)$ (9,621)$ (1,874)$ (12,590)$ (7,323)
Foreign currency translation adjustment2,7732,790635(865)
Comprehensive income (loss)(6,848)916(11,955)(8,188)
Products    
Net revenue:    
Total net revenue[3]51,53863,269104,888107,892
Cost of revenue:    
Total cost of revenue34,33339,24870,03268,098
Services    
Net revenue:    
Total net revenue[4]55,70051,491106,242103,361
Cost of revenue:    
Total cost of revenue$ 37,003$ 32,545$ 65,703$ 65,591
[1]Includes cost of revenue from sales to the joint venture, an equity method investment, of $11,102 and $26,373 during the three and six months ended December 31, 2023 and $9,916 and $15,823 during the three and six months ended December 31, 2022. respectively.
[2]Includes charge backs to the joint venture, an equity method investment, related to research and development of $67 and $199 during the three and six months ended December 31, 2023 and $487 and $1,266 during the three and six months ended December 31, 2022, respectively.
[3]Includes sales of products to the joint venture, an equity method investment, of $17,890 and $39,842 during the three and six months ended December 31, 2023 and $16,715 and $25,584 during the three and six months ended December 31, 2022, respectively. See Note 13.
[4]Includes sales of services to the joint venture, an equity method investment, of $4,134 and $6,988 during the three and six months ended December 31, 2023 and $2,494 and $5,451 during the three and six months ended December 31, 2022, respectively. See Note 13.

ARAY Balance Sheet

2023-12-31
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Current assets:  
Cash and cash equivalents$ 72,756$ 89,402
Restricted cash485524
Accounts receivable, net of allowance for credit losses of $2,866 and $3,079 as of December 31, 2023, and June 30, 2023, respectively[1]77,39774,777
Inventories155,228145,150
Prepaid expenses and other current assets[2]25,02027,612
Deferred cost of revenue284568
Total current assets331,170338,033
Property and equipment, net25,91920,926
Investment in joint venture14,53615,128
Operating lease right-of-use assets, net23,09425,853
Goodwill57,77157,681
Intangible assets, net116210
Restricted cash1,2511,276
Other assets22,49320,107
Total assets476,350479,214
Current liabilities:  
Accounts payable39,18033,739
Accrued compensation21,34523,793
Operating lease liabilities, current5,7074,151
Other accrued liabilities36,25338,271
Customer advances22,67720,777
Deferred revenue77,40672,185
Short-term debt6,7385,721
Total current liabilities209,306198,637
Long-term liabilities:  
Operating lease liabilities, non-current21,75823,602
Long-term other liabilities4,8044,675
Deferred revenue, non-current24,80927,079
Long-term debt168,020171,562
Total liabilities428,697425,555
Commitments and contingencies (Note 8)
Stockholders' equity:  
Common stock, $0.001 par value; authorized: 200,000,000 shares as of December 31, 2023, and June 30, 2023, respectively; issued and outstanding: 99,163,920 and 96,534,609 shares at December 31, 2023, and June 30, 2023, respectively9997
Additional paid-in-capital561,223555,276
Accumulated other comprehensive income1,057422
Accumulated deficit(514,726)(502,136)
Total stockholders' equity47,65353,659
Total liabilities and stockholders' equity$ 476,350$ 479,214
[1]Includes accounts receivable from the joint venture, an equity method investment, of $19,893 and $10,304 at December 31, 2023, and June 30, 2023, respectively. See Note 13.
[2]Includes other receivables from the joint venture, an equity method investment, of $67 and $100 at December 31, 2023, and June 30, 2023, respectively.
ARAY
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
 CEO
 WEBSITEwww.accuray.com
 EMPLOYEES1024

Accuray Inc Frequently Asked Questions


What is the ticker symbol for Accuray Inc? What does ARAY stand for in stocks?

ARAY is the stock ticker symbol of Accuray Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Accuray Inc (ARAY)?

As of Thu Feb 22 2024, market cap of Accuray Inc is 258.83 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ARAY stock?

You can check ARAY's fair value in chart for subscribers.

What is the fair value of ARAY stock?

You can check ARAY's fair value in chart for subscribers. The fair value of Accuray Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Accuray Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ARAY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Accuray Inc a good stock to buy?

The fair value guage provides a quick view whether ARAY is over valued or under valued. Whether Accuray Inc is cheap or expensive depends on the assumptions which impact Accuray Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ARAY.

What is Accuray Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Feb 22 2024, ARAY's PE ratio (Price to Earnings) is -17.79 and Price to Sales (PS) ratio is 0.58. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ARAY PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Accuray Inc's stock?

In the past 10 years, Accuray Inc has provided -0.119 (multiply by 100 for percentage) rate of return.